Deutsche Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Deutsche Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-31,003	Closed	-$3.68M	–	5998
2014 Q4	$3.68M	Buy	31,003 +42	+0.1%	+$4.73K	﹤0.01%	2204
2014 Q3	$3.48M	Buy	30,961 +4,595	+17%	+$437K	﹤0.01%	2094
2014 Q2	$2.5M	Buy	26,366 +14,303	+119%	+$1M	﹤0.01%	2298
2014 Q1	$102K	Sell	12,063 -500	-4%	-$39.6K	﹤0.01%	4230
2013 Q4	$116K	Buy	12,563 +3,152	+33%	+$220K	﹤0.01%	3989
2013 Q3	$81K	Buy	9,411 +278	+3%	+$22.1K	﹤0.01%	4516
2013 Q2	$33K	Buy	+9,133	New	+$673K	﹤0.01%	4645

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Deutsche Bank's VRTX Position: Q2 2026 in Review

Deutsche Bank increased its Vertex Pharmaceuticals (VRTX) stake by 2.7% in Q2 2026, buying an estimated $18.3M and bringing the position to 1,579,110 shares worth $784M. The position accounts for 0.23% of the portfolio, ranked #91.

Deutsche Bank first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $802M in Q4 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Deutsche Bank held 1,579,110 shares of Vertex Pharmaceuticals worth $784M as of Q2 2026.
Deutsche Bank bought 41,374 Vertex Pharmaceuticals shares in Q2 2026, an estimated $18.3M.
Vertex Pharmaceuticals made up 0.23% of Deutsche Bank's portfolio in Q2 2026, its #91 holding.
Deutsche Bank first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
Deutsche Bank's Vertex Pharmaceuticals position peaked at $802M in Q4 2025.
1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.